Streptozotocin-induced diabetic models in mice and rats

Current Protocols in Pharmacology

Volumn , Issue SUPPL. 40, 2008, Pages

  Wu, Kenneth K ^a   Huan, Youming ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperglycemia; Insulin deficiency; Insulitis; Mouse; Rat; Streptozotocin; Type 1 diabetes mellitus

Indexed keywords

STREPTOZOCIN;

DISEASE MODEL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOZOCIN DIABETES;

ANIMAL HUSBANDRY; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 57349184120     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0547s40     Document Type: Review

References (21)

1. Arison, R.N., Ciaccio, E.I., Glitzer, M.S., Cassaro, J.A., and Pruss, M.P. 1967. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16:51-56.
2. Bond, J.S., Failla, M.L., and Unger, D.F. 1983. Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats. J. Biol. Chem. 258:8004-8009.
3. Bonnevie-Nielsen, V., Steffes, M.W., and Lernmark, A. 1981. A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 30:424-429.
4. Breyer, M.D., Bottinger, E., Brosius, F.C. 3rd, Coffman, T.M., Harris, R.C., Heilig, C.W., and Sharma, K., AMDCC. 2005. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16:27-45.
5. Brondum, E., Nilsson, H., and Aalkjaer, C. 2005. Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models. Horm. Metab. Res. 37:56-60.
6. Chan, P., Wong, K.L., Liu, I.M., Tzeng, T.F., Yang, T.L., and Cheng, J.T. 2003. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats. J. Hypertens. 21:761-769.
7. Flood, J.F., Mooradian, A.D., and Morley, J.E. 1990. Characteristics of learning and memory in streptozotocin-induced diabetic mice. Diabetes 39:1391-1398.
8. Ganda, O.P., Rossini, A.A., and Like, A.A. 1976. Studies on streptozotocin diabetes. Diabetes 25:595-603.
9. Hartnell, J.M., Storrie, M.C., and Mooradian, A.D. 1990. Diabetes-related changes in chromatin structure of brain, liver, and intestinal epithelium. Diabetes 39:348-353.
10. Huang, F. and Wu, W. 2005. Antidiabetic effect of a new peptide from Squalus mitsukurii liver (S-8300) in streptozocin-induced diabetic mice. J. Pharm. Pharmacol. 57:1575-1580.
11. Junod, A., Lambert, A.E., Stauffacher, W., and Renold, A.E. 1969. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J. Clin. Invest. 48:2129-2139.
12. Kolb, H. 1987. Mouse models of insulin dependent diabetes: Low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab. Rev. 3:751-778.
13. Kolb-Bachofen, V., Epstein, S., Kiesel, U., and Kolb, H. 1988. Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37:21-27.
14. Kunjathoor, V.V., Wilson, D.L., and LeBoeuf, R.C. 1996. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest. 97:1767-1773.
15. Like, A.A. and Rossini, A.A. 1976. Streptozotocininduced pancreatic insulitis: New model of diabetes mellitus. Science 193:415-417.
16. Mabley, J.G., Rabinovitch, A., Suarez-Pinzon, W., Haskó, G., Pacher, P., Power, R., Southan, G., Salzman, A., and Szabó, C. 2003. Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes. Mol. Med. 9:96-104.
17. Rossini, A.A., Appel, M.C., Williams, R.M., and Like, A.A. 1977. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 26:916-920.
18. Usuki, S., Ito, Y., Morikawa, K., Kise, M., Ariga, T., Rivner, M., and Yu, R.K. 2007. Effect of pregerminated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats. Nutr. Metab. (Lond). 4:25.
19. Weide, L.G. and Lacy, P.E. 1991. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model. Diabetes 40:1157-1162.
20. Wu, K.K. and Huan, Y. 2007. Diabetic atherosclerosis mouse models. Atherosclerosis. 191:241-249.
21. Yin, D., Tao, J., Lee, D.D., Shen, J., Hara, M., Lopez, J., Kuznetsov, A., Philipson, L.H., and Chong, A.S. 2006. Recovery of islet betacell function in streptozotocin-induced diabetic mice: An indirect role for the spleen. Diabetes 55:3256-3263.